Is Arcadia Biosciences a good stock to buy?

The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings. According to analysts' consensus price target of $15.00, Arcadia Biosciences has a forecasted upside of 368.8% from its current price of $3.20. Arcadia Biosciences has only been the subject of 1 research reports in the past 90 days.

Where is Arcadia Biosciences Inc headquartered?

The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Dallas, TX. RKDA | Complete Arcadia Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Should investors buy Arcadia Biosciences (RKDA) stock?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Arcadia Biosciences in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RKDA shares. View RKDA analyst ratings or view top-rated stocks.